#######################
# Document Properties #
#######################
SET DOCUMENT Copyright   = "Copyright Â© 2019 Fraunhofer Institute SCAI, All rights reserved."
SET DOCUMENT Licenses    = "CC BY 4.0"
SET DOCUMENT ContactInfo = "charles.hoyt@scai.fraunhofer.de"

SET DOCUMENT Name        = "Progressive multiple sclerosis: from pathogenic mechanisms to treatment"
SET DOCUMENT Version     = "1.0.0"
SET DOCUMENT Authors     = "Yojana Gadiya"
SET DOCUMENT Description = ""

##############
# Namespaces #
##############

# Namespaces hosted on https://github.com/pharmacome/terminology
# --------------------------------------------------------------
 DEFINE NAMESPACE CHEBI          AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/chebi-names.belns"
# DEFINE NAMESPACE DRUGBANK       AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/drugbank-names.belns"
# DEFINE NAMESPACE DOID           AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c0c576e3d3ab9b25a3982251a4ee2fd7c49e1679/external/doid-names.belns"
# DEFINE NAMESPACE ECCODE         AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/ec-code.belns"
 DEFINE NAMESPACE EFO            AS URL "https://raw.githubusercontent.com/pharmacome/terminology/5d2c2ea6f7112421cc8089a3f021a75ab60bb373/external/efo-names.belns"
# DEFINE NAMESPACE FB             AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/fb-names.belns"
 DEFINE NAMESPACE HBP            AS URL "https://raw.githubusercontent.com/pharmacome/terminology/0816cb6686751420365441adc6a28ced2d272f14/export/conso-names.belns"
DEFINE NAMESPACE HGNC           AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/hgnc-names.belns"
 DEFINE NAMESPACE HGNCGENEFAMILY AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/hgnc.genefamily-names.belns"
 DEFINE NAMESPACE HP             AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/hp-names.belns"
 DEFINE NAMESPACE GO             AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/go-names.belns"
# DEFINE NAMESPACE INTERPRO       AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/interpro-names.belns"
 DEFINE NAMESPACE MESH           AS URL "https://raw.githubusercontent.com/pharmacome/terminology/0816cb6686751420365441adc6a28ced2d272f14/external/mesh-names.belns"
# DEFINE NAMESPACE MGI            AS URL "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/mgi-names.belns"
# DEFINE NAMESPACE MIRBASE        AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/mirbase-names.belns"
 DEFINE NAMESPACE NCBIGENE       AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/ncbigene.belns"
# DEFINE NAMESPACE PFAM           AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/pfam-names.belns"
# DEFINE NAMESPACE RGD            AS URL "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/rgd-names.belns"

# Namespaces hosted on https://github.com/sorgerlab/famplex
# ---------------------------------------------------------
# DEFINE NAMESPACE FPLX           AS URL "https://raw.githubusercontent.com/sorgerlab/famplex/d9ec0526c20795146a9a6aef17496efe1a36cac6/export/famplex.belns"

# Namespaces defined with regular expressions
# -------------------------------------------
 DEFINE NAMESPACE DBSNP          AS PATTERN "rs[0-9]+"
 DEFINE NAMESPACE TAXONOMY       AS PATTERN "^\d+$"
 DEFINE NAMESPACE UNIPROT        AS PATTERN "^([A-N,R-Z][0-9]([A-Z][A-Z, 0-9][A-Z, 0-9][0-9]){1,2})|([O,P,Q][0-9][A-Z, 0-9][A-Z, 0-9][A-Z, 0-9][0-9])(\.\d+)?$"
 DEFINE NAMESPACE PUBCHEM        AS PATTERN "^\d+$"

###############
# Annotations #
###############

# Annotations defined with regular expressions
# --------------------------------------------
DEFINE ANNOTATION Species       AS PATTERN "^\d+$"

# Annotations hosted on https://arty.scai.fraunhofer.de/artifactory/bel/annotation
# --------------------------------------------------------------------------------
 DEFINE ANNOTATION Anatomy       AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno"
 DEFINE ANNOTATION CellLine      AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno"
 DEFINE ANNOTATION CellStructure AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno"
 DEFINE ANNOTATION Cell          AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno"
 DEFINE ANNOTATION Confidence    AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno"
 DEFINE ANNOTATION Disease       AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno"
 DEFINE ANNOTATION Gender        AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/gender/gender-1.0.0.belanno"
 DEFINE ANNOTATION MeSHAnatomy   AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno"
 DEFINE ANNOTATION MeSHDisease   AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno"
 DEFINE ANNOTATION Subgraph      AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/neurommsig/neurommsig-1.0.3.belanno"
 DEFINE ANNOTATION TextLocation  AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"

##############
# Statements #
##############
SET Citation = {"PubMed", "27794524"}

SET Evidence = "Multiple sclerosis is a chronic inflammatory disease of the
CNS leading to demyelination and neurodegeneration."
path(MESH:"Multiple Sclerosis") isA path(MESH:"Central Nervous System Diseases")
path(MESH:"Multiple Sclerosis") -> path(MESH:"Demyelinating Diseases")
path(MESH:"Multiple Sclerosis") -> path(MESH:"Neurodegenerative Diseases")

SET Evidence = "Results from immunological, genetic and histopathology studies of patients with
multiple sclerosis support the concept that autoimmunity
plays a major role in disease pathogenesis (McFarland
and Martin, 2007)"
path(MESH:Autoimmunity) -- path(MESH:"Multiple Sclerosis")

SET Evidence = "The course of multiple sclerosis is highly variable; nevertheless
in most patients, multiple sclerosis is characterized
by the onset of recurring clinical symptoms followed by
total or partial recovery, namely, the classic relapsingremitting
form of multiple sclerosis (RRMS)."
#RRMS: Multiple Sclerosis, Relapsing-Remitting
path(MESH:"Multiple Sclerosis") -> path(MESH:"Multiple Sclerosis, Relapsing-Remitting")

SET Evidence = "One suggests that brain damage is driven by inflammatory processes similar
to those observed during RRMS; but that during progressive disease stages, a microenvironment is created within the CNS favouring homing and retention of inflammatory cells, ultimately causing disease-modifying therapies to become largely ineffective (Frischer et al., 2009)."
path(MESH:"Multiple Sclerosis, Relapsing-Remitting") -> bp(GO:"inflammatory response")
bp(GO:"inflammatory response") neg bp(GO:"brain development")
bp(GO:"central nervous system development") pos bp(GO:"inflammatory response")
bp(GO:"inflammatory response") -> path(MESH:"Disease Resistance")

SET Evidence = "Although brain and spinal cord inflammation are present in
RRMS, SPMS, and PPMS its extent declines with age and
disease duration."
#secondary progressive multiple sclerosis (SPMS) - Multiple Sclerosis, Chronic Progressive
#primary progressive multiple sclerosis (PPMS) - Multiple Sclerosis, Chronic Progressive
SET MeSHAnatomy = "Brain"
SET Anatomy = "spinal cord"
path(MESH:"Multiple Sclerosis, Chronic Progressive") -> path(MESH:Inflammation)
path(MESH:"Multiple Sclerosis, Relapsing-Remitting") -> path(MESH:Inflammation)
path(MESH:Aging) -| path(MESH:Inflammation)
path(MESH:"Disease Resistance") -> path(MESH:Inflammation)
UNSET MeSHAnatomy
UNSET Anatomy

SET Evidence = "Among potential candidates driving inflammation during progressive
multiple sclerosis, the role of B cells appears to be prominent,
particularly in the context of meningeal inflammation
(Magliozzi et al., 2007)."
#Meningitis - meningeal inflammation
path(MESH:"B-Lymphocytes") -- path(MESH:Meningitis)

SET Evidence = "B cell functions that could be of
relevance in progressive multiple sclerosis include: antibody
production, cytokine secretion, antigen presentation and
ectopic formation of follicle-like structures, a pathological
feature shared with other chronic inflammatory diseases
(Aloisi and Pujol-Borrell, 2006)."
#Tertiary Lymphoid Structures - Ectopic Lymphoid Follicles
SET Disease = "multiple sclerosis"
p(MESH:"B-Lymphocytes") -> path(MESH:"Antibody Formation")
p(MESH:"B-Lymphocytes") -> sec(a(MESH:Cytokines))
p(MESH:"B-Lymphocytes") -> path(MESH:"Antigen Presentation")
p(MESH:"B-Lymphocytes") -> path(MESH:"Tertiary Lymphoid Structures")
UNSET Disease

SET Evidence = "Furthermore, increased secretion
of pro-inflammatory cytokines such as lymphotoxin,
tumour necrosis factor alpha (TNF-alpha), and interleukin
(IL)-6, or deficient production of regulatory cytokines
including IL-10 or IL-35 may impact complement activation
and T cell function (Bar-Or et al., 2010)."
#LTA - lymphotoxin
#complex(p(HGNC:IL12A), p(HGNC:EBI3)) - IL-35
p(HGNC:TNF) isA a(MESH:Cytokines)
p(HGNC:LTA) isA a(MESH:Cytokines)
p(HGNC:IL6) isA a(MESH:Cytokines)
p(HGNC:IL10) reg a(MESH:Cytokines)
complex(p(HGNC:IL12A), p(HGNC:EBI3)) reg a(MESH:Cytokines)
p(HGNC:TNF) pos path(MESH:"Complement Activation")
p(HGNC:LTA) pos path(MESH:"Complement Activation")
p(HGNC:IL6) pos path(MESH:"Complement Activation")
p(HGNC:IL10) neg path(MESH:"Complement Activation")
complex(p(HGNC:IL12A), p(HGNC:EBI3)) neg path(MESH:"Complement Activation")
p(HGNC:TNF) pos act(p(MESH:"T-Lymphocytes"))
p(HGNC:LTA) pos act(p(MESH:"T-Lymphocytes"))
p(HGNC:IL6) pos act(p(MESH:"T-Lymphocytes"))
p(HGNC:IL10) neg act(p(MESH:"T-Lymphocytes"))
complex(p(HGNC:IL12A), p(HGNC:EBI3)) neg act(p(MESH:"T-Lymphocytes"))

SET Evidence = "Thus, this compartmental CNS B
cell immune response may be able to drive CNS injury
independent of peripheral immune activity (Lovato et al.,
2011)."
SET Anatomy = "central nervous system"
p(MESH:"B-Lymphocytes") -> path(MESH:"Wounds and Injuries")
path(MESH:Immunity) cnc act(p(MESH:"B-Lymphocytes"))

SET Evidence = "Follicle-like structures have recently been found in
the subarachnoid space of leptomeninges, close to inflamed
blood vessels. Composition of these infiltrates included:
proliferating B lymphocytes, plasma cells, helper T lymphocytes
and a network of follicular dendritic cells (Serafini
et al., 2004; Magliozzi et al., 2007)."
SET Anatomy = "subarachnoid space"
complex(p(HGNC:IL12A), p(HGNC:EBI3)) hasComponents list(a(MESH:"B-Lymphocytes"), a(MESH:"Plasma Cells"), a(MESH:"T-Lymphocytes, Helper-Inducer"), a(MESH:"Dendritic Cells, Follicular"))
UNSET Anatomy

SET Evidence = "Follicular dendritic cells within follicle-like
structure produce CXCL13, which is important for recruitment,
as well as maturation and antigenic selection of B
cells (Corsiero et al., 2012)."
a(MESH:"Dendritic Cells, Follicular") -> sec(p(HGNC:CXCL13))
p(HGNC:CXCL13) pos path(MESH:"B-Cell Maturation Antigen")
p(HGNC:CXCL13) pos bp(GO:"regulation of B cell chemotaxis")
p(HGNC:CXCL13) pos bp(GO:"B cell selection")

SET Evidence - "However, clonally-restricted
B cells have been found in CSF from patients with RRMS
(Kuenz et al., 2008) indicating intrathecal clonal expansion
of B cells."
